Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Developmental and molecular contributions to contextual fear memory emergence in mice
    Published on 2024-03-04
    1 year ago
  • Mediodorsal thalamus projection to medial prefrontal cortical mediates social defeat stress-induced depression-like behaviors
    Published on 2024-03-03
    1 year ago
  • Reply to Bisol: Critical review and recommendations for enhancement of the article on novel neurosteroid therapeutics for postpartum depression
    Published on 2024-03-03
    1 year ago
  • Matrix metalloproteinase 9 (MMP-9) activity, hippocampal extracellular free water, and cognitive deficits are associated with each other in early phase psychosis
    Published on 2024-03-01
    1 year ago
  • Effects of gene dosage and development on subcortical nuclei volumes in individuals with 22q11.2 copy number variations
    Published on 2024-03-01
    1 year ago
  • Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors
    Published on 2024-02-29
    1 year ago
  • GABA release from central amygdala neurotensin neurons differentially modulates ethanol consumption in male and female mice
    Published on 2024-02-27
    1 year ago
« Previous 1 … 47 48 49 50 51 … 143 Next »
Journal of Psychopharmacology
  • Efficacy of aripiprazole as adjunctive therapy in major depressive disorder with somatic symptoms: A randomized, double-blind, placebo-controlled trial with clinical and electroencephalography evidence
    Published on 2022-10-14
    3 years ago
  • Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze
    Published on 2022-10-14
    3 years ago
  • Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration–effect relations using the IB-de-risk tool
    Published on 2022-10-14
    3 years ago
  • Commentary on Cochrane review: “Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder”
    Published on 2022-10-11
    3 years ago
  • Pharmaco-fUS in cognitive impairment: Lessons from a preclinical model
    Published on 2022-10-07
    3 years ago
  • Associations between MDMA/ecstasy use and physical health in a U.S. population-based survey sample
    Published on 2022-10-03
    3 years ago
  • The low risk for early renal damage during lithium treatment has not changed over time
    Published on 2022-09-19
    3 years ago
« Previous 1 … 47 48 49 50 51 … 124 Next »
European Neuropsychopharmacology
  • New biomarkers in mood disorders: Insights from immunopsychiatry and neuroimaging
    Published on 2023-02-13
    2 years ago
  • A shared decision journey to bridge the gap between treatment recommendation and low adherence?
    Published on 2023-02-13
    2 years ago
  • Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence
    Published on 2023-02-13
    2 years ago
  • Treating major depressive disorder with mixed features
    Published on 2023-02-13
    2 years ago
  • In vivo serotonin transporter and 1A receptor binding potential and ecological momentary assessment (EMA) of stress in major depression and suicidal behavior
    Published on 2023-02-12
    2 years ago
  • Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes
    Published on 2023-02-08
    2 years ago
  • Initial response to the COVID-19 pandemic on real-life well-being, social contact and roaming behavior in patients with schizophrenia, major depression and healthy controls: A longitudinal ecological momentary assessment study
    Published on 2023-02-03
    2 years ago
« Previous 1 … 47 48 49 50 51 … 145 Next »

   Pharma Pub